| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 1.177.454.704 $ | 97,53 | 7.875.408 | ||||||
| Eli Lilly and Co. | Eli Lilly and Co. | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 127.891.166 $ | 10,59 | 111.322 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 81.643.630 $ | 6,76 | 318.485 | |
| UnitedHealth Group Inc. | UnitedHealth Group Inc. | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 74.439.086 $ | 6,17 | 179.631 | |
| Merck & Co., Inc. | Merck & Co., Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 55.416.505 $ | 4,59 | 425.626 | |
| AbbVie Inc. | AbbVie Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 48.603.063 $ | 4,03 | 193.684 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 43.881.291 $ | 3,63 | 337.004 | |
| argenx SE | argenx SE, ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 39.079.341 $ | 3,24 | 45.770 | |
| CVS Health Corp. | CVS Health Corp. | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 30.421.817 $ | 2,52 | 291.313 | |
| Welltower Inc. | Welltower Inc. | EC | 95040Q104 | Long | Börsenkurs (Stufe 1) | 28.236.188 $ | 2,34 | 120.441 | |
| BrightSpring Health Services, Inc. | BrightSpring Health Services, Inc. | EC | 10950A106 | Long | Börsenkurs (Stufe 1) | 26.546.887 $ | 2,20 | 444.597 | |
| Royalty Pharma PLC | Royalty Pharma PLC, Class A | EC | G7709Q104 | Long | Börsenkurs (Stufe 1) | 25.767.046 $ | 2,13 | 440.990 | |
| Cardinal Health, Inc. | Cardinal Health, Inc. | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 25.338.265 $ | 2,10 | 110.152 | |
| Guardant Health, Inc. | Guardant Health, Inc. | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 24.651.314 $ | 2,04 | 152.178 | |
| Vertex Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 24.312.062 $ | 2,01 | 50.958 | |
| Axsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 19.117.723 $ | 1,58 | 87.700 | |
| Edwards Lifesciences Corp. | Edwards Lifesciences Corp. | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 18.857.421 $ | 1,56 | 219.094 | |
| Thermo Fisher Scientific Inc. | Thermo Fisher Scientific Inc. | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 18.739.983 $ | 1,55 | 32.631 | |
| BridgeBio Pharma, Inc. | BridgeBio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 17.317.620 $ | 1,43 | 216.227 | |
| Waters Corp. | Waters Corp. | EC | 941848103 | Long | Börsenkurs (Stufe 1) | 17.036.678 $ | 1,41 | 45.153 | |
| IQVIA Holdings Inc. | IQVIA Holdings Inc. | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 15.926.835 $ | 1,32 | 67.768 | |
| U C B S.A. | U C B S.A. | EC | B93562120 | Long | Modellwert (Stufe 2) | 14.954.119 $ | 1,24 | 58.259 | |
| Ligand Pharmaceuticals Inc. | Ligand Pharmaceuticals Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 14.206.776 $ | 1,18 | 49.408 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 14.204.001 $ | 1,18 | 103.952 | |
| Natera, Inc. | Natera, Inc. | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 14.102.919 $ | 1,17 | 52.670 | |
| Sandoz Group AG | Sandoz Group AG | EC | H7140B103 | Long | Modellwert (Stufe 2) | 13.793.551 $ | 1,14 | 169.209 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | K08588103 | Long | Börsenkurs (Stufe 1) | 13.195.775 $ | 1,09 | 54.101 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 13.101.971 $ | 1,09 | 69.866 | |
| Amgen Inc. | Amgen Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 12.867.040 $ | 1,07 | 33.407 | |
| Halozyme Therapeutics, Inc. | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 12.801.789 $ | 1,06 | 155.098 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 11.927.003 $ | 0,99 | 23.038 | |
| Quest Diagnostics Inc. | Quest Diagnostics Inc. | EC | 74834L100 | Long | Börsenkurs (Stufe 1) | 11.873.258 $ | 0,98 | 50.956 | |
| Mettler-Toledo International Inc. | Mettler-Toledo International Inc. | EC | 592688105 | Long | Börsenkurs (Stufe 1) | 11.109.457 $ | 0,92 | 7.844 | |
| Charles River Laboratories International, Inc. | Charles River Laboratories International, Inc. | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 11.051.898 $ | 0,92 | 47.533 | |
| Intuitive Surgical, Inc. | Intuitive Surgical, Inc. | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 10.842.638 $ | 0,90 | 30.687 | |
| Galderma Group AG | Galderma Group AG, Class A | EC | H3301B107 | Long | Modellwert (Stufe 2) | 10.820.940 $ | 0,90 | 49.726 | |
| Medline Inc. | Medline Inc. | EC | 58507V107 | Long | Börsenkurs (Stufe 1) | 10.397.730 $ | 0,86 | 264.708 | |
| Madrigal Pharmaceuticals, Inc. | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 9.889.426 $ | 0,82 | 21.162 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | G0593M107 | Long | Börsenkurs (Stufe 1) | 9.533.089 $ | 0,79 | 56.196 | |
| West Pharmaceutical Services, Inc. | West Pharmaceutical Services, Inc. | EC | 955306105 | Long | Börsenkurs (Stufe 1) | 9.524.377 $ | 0,79 | 27.934 | |
| Labcorp Holdings Inc. | Labcorp Holdings Inc. | EC | 504922105 | Long | Börsenkurs (Stufe 1) | 8.589.576 $ | 0,71 | 27.780 | |
| Lonza Group AG | Lonza Group AG | EC | H50524133 | Long | Modellwert (Stufe 2) | 8.522.644 $ | 0,71 | 12.228 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 8.317.622 $ | 0,69 | 107.839 | |
| Tenet Healthcare Corp. | Tenet Healthcare Corp. | EC | 88033G407 | Long | Börsenkurs (Stufe 1) | 8.032.704 $ | 0,67 | 31.528 | |
| Steris PLC | Steris PLC | EC | G8473T100 | Long | Börsenkurs (Stufe 1) | 7.564.836 $ | 0,63 | 33.121 | |
| Krystal Biotech, Inc. | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 6.937.357 $ | 0,57 | 20.337 | |
| Arrowhead Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 6.925.555 $ | 0,57 | 81.814 | |
| Globus Medical, Inc. | Globus Medical, Inc., Class A | EC | 379577208 | Long | Börsenkurs (Stufe 1) | 6.901.846 $ | 0,57 | 87.598 | |
| Twist Bioscience Corp. | Twist Bioscience Corp. | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 6.839.517 $ | 0,57 | 74.708 | |
| Medpace Holdings, Inc. | Medpace Holdings, Inc. | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 6.805.858 $ | 0,56 | 11.793 | |
| Encompass Health Corp. | Encompass Health Corp. | EC | 29261A100 | Long | Börsenkurs (Stufe 1) | 5.939.690 $ | 0,49 | 53.477 | |
| Alignment Healthcare, Inc. | Alignment Healthcare, Inc. | EC | 01625V104 | Long | Börsenkurs (Stufe 1) | 5.706.959 $ | 0,47 | 384.307 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 5.658.044 $ | 0,47 | 57.008 | |
| Humana Inc. | Humana Inc. | EC | 444859102 | Long | Börsenkurs (Stufe 1) | 5.474.274 $ | 0,45 | 15.045 | |
| Praxis Precision Medicines, Inc. | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 5.102.282 $ | 0,42 | 16.575 | |
| Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries Ltd., ADR | EC | 881624209 | Long | Börsenkurs (Stufe 1) | 5.061.466 $ | 0,42 | 144.572 | |
| Cogent Biosciences, Inc. | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 4.834.522 $ | 0,40 | 124.185 | |
| Mirum Pharmaceuticals, Inc. | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 4.772.306 $ | 0,40 | 45.043 | |
| BioLife Solutions, Inc. | BioLife Solutions, Inc. | EC | 09062W204 | Long | Börsenkurs (Stufe 1) | 4.743.831 $ | 0,39 | 151.657 | |
| BillionToOne, Inc. | BillionToOne, Inc. | EC | 090168105 | Long | Börsenkurs (Stufe 1) | 4.657.792 $ | 0,39 | 33.606 | |
| Rapport Therapeutics, Inc. | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 4.506.407 $ | 0,37 | 109.966 | |
| LeMaitre Vascular, Inc. | LeMaitre Vascular, Inc. | EC | 525558201 | Long | Börsenkurs (Stufe 1) | 4.462.031 $ | 0,37 | 44.039 | |
| Centene Corp. | Centene Corp. | EC | 15135B101 | Long | Börsenkurs (Stufe 1) | 4.044.736 $ | 0,34 | 65.007 | |
| RadNet, Inc. | RadNet, Inc. | EC | 750491102 | Long | Börsenkurs (Stufe 1) | 4.001.047 $ | 0,33 | 62.732 | |
| IDEXX Laboratories, Inc. | IDEXX Laboratories, Inc. | EC | 45168D104 | Long | Börsenkurs (Stufe 1) | 3.879.946 $ | 0,32 | 6.940 | |
| Glaukos Corp. | Glaukos Corp. | EC | 377322102 | Long | Börsenkurs (Stufe 1) | 3.763.204 $ | 0,31 | 22.572 | |
| Dianthus Therapeutics, Inc. | Dianthus Therapeutics, Inc. | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 3.594.437 $ | 0,30 | 33.618 | |
| Xenon Pharmaceuticals Inc. | Xenon Pharmaceuticals Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 3.299.325 $ | 0,27 | 52.646 | |
| Bruker Corp. | Bruker Corp. | EC | 116794108 | Long | Börsenkurs (Stufe 1) | 3.178.447 $ | 0,26 | 50.580 | |
| Heartflow, Inc. | Heartflow, Inc. | EC | 42238D107 | Long | Börsenkurs (Stufe 1) | 3.057.321 $ | 0,25 | 121.178 | |
| Tarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 2.984.236 $ | 0,25 | 50.546 | |
| Palvella Therapeutics, Inc. | Palvella Therapeutics, Inc. | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 2.889.668 $ | 0,24 | 20.783 | |
| Incyte Corp. | Incyte Corp. | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 2.694.698 $ | 0,22 | 22.546 | |
| uniQure N.V. | uniQure N.V. | EC | N90064101 | Long | Börsenkurs (Stufe 1) | 2.302.050 $ | 0,19 | 52.763 | |
| Edgewise Therapeutics, Inc. | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 1.698.183 $ | 0,14 | 44.189 | |
| Kiniksa Pharmaceuticals International, PLC | Kiniksa Pharmaceuticals International, PLC | EC | G52694109 | Long | Börsenkurs (Stufe 1) | 1.676.070 $ | 0,14 | 22.546 | |
| Phathom Pharmaceuticals, Inc. | Phathom Pharmaceuticals, Inc. | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 1.617.963 $ | 0,13 | 184.910 | |
| GMR Solutions Inc. | GMR Solutions Inc. | EC | 38013D106 | Long | Börsenkurs (Stufe 1) | 1.555.221 $ | 0,13 | 120.747 | |
| Mineralys Therapeutics, Inc. | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 1.439.354 $ | 0,12 | 56.401 | |
| Gesamt | 1.177.454.704 $ | 97,53 | 7.875.408 |